Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.58 - $6.13 $54,763 - $130,115
-21,226 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$4.42 - $10.61 $4,092 - $9,824
926 Added 4.56%
21,226 $120,000
Q2 2021

Aug 16, 2021

SELL
$9.15 - $20.17 $52,923 - $116,663
-5,784 Reduced 22.17%
20,300 $218,000
Q1 2021

May 17, 2021

SELL
$18.76 - $40.91 $261,064 - $569,303
-13,916 Reduced 34.79%
26,084 $583,000
Q4 2020

Feb 16, 2021

BUY
$27.6 - $48.03 $1.1 Million - $1.92 Million
40,000 New
40,000 $1.92 Million

About Sigilon Therapeutics, Inc.


  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.